The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Apr 2, 2025 | Narula Sanjeev | Executive Vice President & CFO | Disposed to issuer(D) | 17K | — | — |
| Apr 2, 2025 | Narula Sanjeev | Executive Vice President & CFO | Disposed to issuer(D) | 35K | — | — |
| Apr 2, 2025 | Narula Sanjeev | Executive Vice President & CFO | Disposed to issuer(D) | 23K | — | — |
| Apr 2, 2025 | Durgam Suresh K. | EVP, Chief Medical Officer | Disposed to issuer(D) | 43K | $132.00 | $5.7M |
| Apr 2, 2025 | Durgam Suresh K. | EVP, Chief Medical Officer | Disposed to issuer(D) | 33K | — | — |
| Apr 2, 2025 | Durgam Suresh K. | EVP, Chief Medical Officer | Disposed to issuer(D) | 13K | — | — |
| Apr 2, 2025 | Durgam Suresh K. | EVP, Chief Medical Officer | Grant(A) | 13K | — | $0 |
| Apr 2, 2025 | Durgam Suresh K. | EVP, Chief Medical Officer | Disposed to issuer(D) | 25K | — | — |
| Apr 2, 2025 | Durgam Suresh K. | EVP, Chief Medical Officer | Disposed to issuer(D) | 17K | — | — |
| Apr 2, 2025 | Durgam Suresh K. | EVP, Chief Medical Officer | Disposed to issuer(D) | 13K | — | — |
| Apr 2, 2025 | Durgam Suresh K. | EVP, Chief Medical Officer | Disposed to issuer(D) | 18K | — | — |
| Apr 2, 2025 | Durgam Suresh K. | EVP, Chief Medical Officer | Disposed to issuer(D) | 19K | — | — |
| Apr 2, 2025 | Durgam Suresh K. | EVP, Chief Medical Officer | Disposed to issuer(D) | 9K | — | — |
| Apr 2, 2025 | Durgam Suresh K. | EVP, Chief Medical Officer | Grant(A) | 9K | — | $0 |
| Apr 2, 2025 | Durgam Suresh K. | EVP, Chief Medical Officer | Disposed to issuer(D) | 54K | — | — |
| Apr 2, 2025 | Mates Sharon | Chairman and CEO, Director | Disposed to issuer(D) | 190K | $132.00 | $25.1M |
| Apr 2, 2025 | Mates Sharon | Chairman and CEO, Director | Disposed to issuer(D) | 945K | $132.00 | $124.8M |
| Apr 2, 2025 | Mates Sharon | Chairman and CEO, Director | Grant(A) | 35K | — | $0 |
| Apr 2, 2025 | Mates Sharon | Chairman and CEO, Director | Disposed to issuer(D) | 41K | — | — |
| Apr 2, 2025 | Mates Sharon | Chairman and CEO, Director | Grant(A) | 41K | — | $0 |
| Apr 2, 2025 | Mates Sharon | Chairman and CEO, Director | Disposed to issuer(D) | 121K | — | — |
| Apr 2, 2025 | Mates Sharon | Chairman and CEO, Director | Disposed to issuer(D) | 86K | — | — |
| Apr 2, 2025 | Mates Sharon | Chairman and CEO, Director | Disposed to issuer(D) | 41K | — | — |
| Apr 2, 2025 | Mates Sharon | Chairman and CEO, Director | Disposed to issuer(D) | 50K | — | — |
| Apr 2, 2025 | Mates Sharon | Chairman and CEO, Director | Disposed to issuer(D) | 53K | — | — |
| Apr 2, 2025 | Mates Sharon | Chairman and CEO, Director | Disposed to issuer(D) | 67K | — | — |
| Apr 2, 2025 | Mates Sharon | Chairman and CEO, Director | Disposed to issuer(D) | 138K | — | — |
| Apr 2, 2025 | Mates Sharon | Chairman and CEO, Director | Disposed to issuer(D) | 135K | — | — |
| Apr 2, 2025 | Mates Sharon | Chairman and CEO, Director | Disposed to issuer(D) | 35K | — | — |
| Apr 2, 2025 | Mates Sharon | Chairman and CEO, Director | Disposed to issuer(D) | 70K | — | — |
| Apr 2, 2025 | Marcus Joel S | Director | Disposed to issuer(D) | 10K | $132.00 | $1.3M |
| Apr 2, 2025 | Marcus Joel S | Director | Disposed to issuer(D) | 48K | $132.00 | $6.4M |
| Apr 2, 2025 | Marcus Joel S | Director | Disposed to issuer(D) | 3K | — | — |
| Apr 2, 2025 | Marcus Joel S | Director | Disposed to issuer(D) | 4K | — | — |
| Apr 2, 2025 | Neumann Mark | EVP, Chief Commercial Officer | Disposed to issuer(D) | 53K | $132.00 | $7.0M |
| Apr 2, 2025 | Neumann Mark | EVP, Chief Commercial Officer | Disposed to issuer(D) | 17K | — | — |
| Apr 2, 2025 | Neumann Mark | EVP, Chief Commercial Officer | Disposed to issuer(D) | 23K | — | — |
| Apr 2, 2025 | Neumann Mark | EVP, Chief Commercial Officer | Grant(A) | 13K | — | $0 |
| Apr 2, 2025 | Neumann Mark | EVP, Chief Commercial Officer | Disposed to issuer(D) | 13K | — | — |
| Apr 2, 2025 | Neumann Mark | EVP, Chief Commercial Officer | Grant(A) | 9K | — | $0 |
| Apr 2, 2025 | Neumann Mark | EVP, Chief Commercial Officer | Disposed to issuer(D) | 9K | — | — |
| Apr 2, 2025 | Neumann Mark | EVP, Chief Commercial Officer | Disposed to issuer(D) | 18K | — | — |
| Apr 2, 2025 | Neumann Mark | EVP, Chief Commercial Officer | Disposed to issuer(D) | 13K | — | — |
| Apr 2, 2025 | Van Nostrand Robert L | Director | Disposed to issuer(D) | 11K | $132.00 | $1.5M |
| Apr 2, 2025 | Van Nostrand Robert L | Director | Disposed to issuer(D) | 20K | — | — |
| Apr 2, 2025 | Van Nostrand Robert L | Director | Disposed to issuer(D) | 17K | — | — |
| Apr 2, 2025 | Van Nostrand Robert L | Director | Disposed to issuer(D) | 20K | — | — |
| Apr 2, 2025 | Van Nostrand Robert L | Director | Disposed to issuer(D) | 20K | — | — |
| Apr 2, 2025 | Van Nostrand Robert L | Director | Disposed to issuer(D) | 20K | — | — |
| Apr 2, 2025 | Van Nostrand Robert L | Director | Disposed to issuer(D) | 20K | — | — |
| Apr 2, 2025 | Van Nostrand Robert L | Director | Disposed to issuer(D) | 3K | — | — |
| Apr 2, 2025 | Van Nostrand Robert L | Director | Disposed to issuer(D) | 7K | — | — |
| Apr 2, 2025 | Van Nostrand Robert L | Director | Disposed to issuer(D) | 4K | — | — |
| Apr 2, 2025 | Halstead Michael | President | Disposed to issuer(D) | 21K | $132.00 | $2.8M |
| Apr 2, 2025 | Halstead Michael | President | Disposed to issuer(D) | 24K | — | — |
| Apr 2, 2025 | Halstead Michael | President | Disposed to issuer(D) | 45K | — | — |
| Apr 2, 2025 | Halstead Michael | President | Disposed to issuer(D) | 13K | — | — |
| Apr 2, 2025 | Halstead Michael | President | Grant(A) | 12K | — | $0 |
| Apr 2, 2025 | Halstead Michael | President | Disposed to issuer(D) | 12K | — | — |
| Apr 2, 2025 | Halstead Michael | President | Disposed to issuer(D) | 13K | — | — |
| Apr 2, 2025 | Halstead Michael | President | Disposed to issuer(D) | 18K | — | — |
| Apr 2, 2025 | Halstead Michael | President | Disposed to issuer(D) | 40K | — | — |
| Apr 2, 2025 | Halstead Michael | President | Grant(A) | 13K | — | $0 |
| Apr 2, 2025 | Riggs Rory B | Director | Disposed to issuer(D) | 132K | $132.00 | $17.4M |
| Apr 2, 2025 | Riggs Rory B | Director | Disposed to issuer(D) | 7K | — | — |
| Apr 2, 2025 | Riggs Rory B | Director | Disposed to issuer(D) | 4K | — | — |
| Apr 2, 2025 | Riggs Rory B | Director | Disposed to issuer(D) | 17K | — | — |
| Apr 2, 2025 | Riggs Rory B | Director | Disposed to issuer(D) | 20K | — | — |
| Apr 2, 2025 | Riggs Rory B | Director | Disposed to issuer(D) | 20K | — | — |
| Apr 2, 2025 | Riggs Rory B | Director | Disposed to issuer(D) | 3K | — | — |
| Apr 2, 2025 | Riggs Rory B | Director | Disposed to issuer(D) | 20K | — | — |
| Apr 2, 2025 | Riggs Rory B | Director | Disposed to issuer(D) | 20K | — | — |
| Apr 2, 2025 | Salas Eduardo Rene | Director | Disposed to issuer(D) | 2K | $132.00 | $207K |
| Apr 2, 2025 | Salas Eduardo Rene | Director | Disposed to issuer(D) | 17K | — | — |
| Apr 2, 2025 | Salas Eduardo Rene | Director | Disposed to issuer(D) | 20K | — | — |
| Apr 2, 2025 | Salas Eduardo Rene | Director | Disposed to issuer(D) | 4K | — | — |
| Apr 2, 2025 | Salas Eduardo Rene | Director | Disposed to issuer(D) | 3K | — | — |
| Apr 2, 2025 | Salas Eduardo Rene | Director | Disposed to issuer(D) | 7K | — | — |
| Mar 26, 2025 | Mates Sharon | Chairman and CEO, Director | Gift(G) | 190K | — | $0 |
| Mar 26, 2025 | Mates Sharon | Chairman and CEO, Director | Gift(G) | 190K | — | $0 |
| Mar 10, 2025 | Halstead Michael | President | Option exercise(M) | 7K | — | — |
| Mar 10, 2025 | Halstead Michael | President | Tax withholding(F) | 4K | $131.24 | $493K |
| Mar 10, 2025 | Halstead Michael | President | Option exercise(M) | 7K | — | $0 |
| Mar 10, 2025 | Neumann Mark | EVP, Chief Commercial Officer | Tax withholding(F) | 3K | $131.24 | $409K |
| Mar 10, 2025 | Neumann Mark | EVP, Chief Commercial Officer | Option exercise(M) | 7K | — | — |
| Mar 10, 2025 | Neumann Mark | EVP, Chief Commercial Officer | Option exercise(M) | 7K | — | $0 |
| Mar 10, 2025 | Mates Sharon | Chairman and CEO, Director | Tax withholding(F) | 10K | $131.24 | $1.3M |
| Mar 10, 2025 | Mates Sharon | Chairman and CEO, Director | Option exercise(M) | 21K | — | — |
| Mar 10, 2025 | Mates Sharon | Chairman and CEO, Director | Option exercise(M) | 21K | — | $0 |
| Mar 10, 2025 | Durgam Suresh K. | EVP, Chief Medical Officer | Tax withholding(F) | 3K | $131.24 | $409K |
| Mar 10, 2025 | Durgam Suresh K. | EVP, Chief Medical Officer | Option exercise(M) | 7K | — | — |
| Mar 10, 2025 | Durgam Suresh K. | EVP, Chief Medical Officer | Option exercise(M) | 7K | — | $0 |
| Mar 6, 2025 | Halstead Michael | President | Tax withholding(F) | 7K | $131.19 | $881K |
| Mar 6, 2025 | Halstead Michael | President | Option exercise(M) | 13K | — | — |
| Mar 6, 2025 | Halstead Michael | President | Option exercise(M) | 13K | — | $0 |
| Mar 6, 2025 | Neumann Mark | EVP, Chief Commercial Officer | Tax withholding(F) | 6K | $131.19 | $731K |
| Mar 6, 2025 | Neumann Mark | EVP, Chief Commercial Officer | Option exercise(M) | 13K | — | — |
| Mar 6, 2025 | Neumann Mark | EVP, Chief Commercial Officer | Option exercise(M) | 13K | — | $0 |
| Mar 6, 2025 | Mates Sharon | Chairman and CEO, Director | Option exercise(M) | 41K | — | — |
| Mar 6, 2025 | Mates Sharon | Chairman and CEO, Director | Tax withholding(F) | 20K | $131.19 | $2.6M |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Coverage: Form 4 filings indexed 2021-03-29 → 2026-07-14. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).